Hospital
Russellville Hospital INC.
Russellville Hospital INC. was paid $1.34M by Medicaid between Jan 2018 and Nov 2024, across 55 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoRUSSELLVILLE HOSPITAL INC.
RUSSELLVILLE, AL 35653
RUSSELLVILLE, AL 35653
33aNPI1316015241assigned 11/30/2006
33bProvider typeRural Acute Care Hospital
28Total paid$1.34M
24GClaims48,014
24DCodes billed55
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Alabama
Rank by total paid#6 of 11
Median peer was paid$1.34M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,275 | $168K | |
| 2019 | 10,034 | $170K | |
| 2020 | 5,290 | $93K | |
| 2021 | 6,459 | $138K | |
| 2022 | 6,797 | $274K | |
| 2023 | 6,876 | $346K | |
| 2024incomplete | 3,283 | $148K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 6,009 | 5,632 | $410K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 9,381 | 8,826 | $348K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 950 | 890 | $245K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.7% | 3,963 | 2,454 | $63K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.3% | 1,546 | 1,488 | $44K |
| 80053 | Comprehensive metabolic panel | 3.2% | 4,413 | 4,125 | $43K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.0% | 2,516 | 2,359 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 5,368 | 4,990 | $38K |
| 87081 | 1.4% | 1,920 | 1,799 | $19K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 831 | 811 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 705 | 697 | $13K |
| 80061 | Lipid panel | <1% | 707 | 698 | $12K |
43 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 217 | $8K |
| 81001 | <1% | 2,105 | $8K | |
| 80306 | <1% | 544 | $5K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 132 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 303 | $3K |
| 84436 | <1% | 565 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 25 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 736 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 24 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 309 | $2K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 20 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 401 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 681 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 14 | $707.28 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 561 | $646.18 |
| 82553 | <1% | 12 | $474.41 | |
| 84484 | <1% | 15 | $456.74 | |
| 97602 | <1% | 38 | $447.20 | |
| 82550 | <1% | 12 | $437.36 | |
| 83721 | <1% | 49 | $431.04 | |
| 87070 | <1% | 35 | $399.63 | |
| 82150 | <1% | 75 | $395.43 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 45 | $377.44 |
| 87807 | <1% | 33 | $358.15 | |
| 83690 | <1% | 61 | $315.12 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 413 | $283.80 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 30 | $234.65 |
| 81025 | <1% | 68 | $223.31 | |
| 86677 | <1% | 14 | $213.90 | |
| 0011A | <1% | 48 | $200.00 | |
| 0012A | <1% | 41 | $160.00 | |
| 81003 | <1% | 42 | $78.96 | |
| J2704 | Injection, propofol, 10 mg | <1% | 812 | $64.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 152 | $32.96 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 73 | $3.52 |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | <1% | 13 | $2.93 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 74 | $1.26 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 139 | $0.48 |
| A9270 | Non-covered item or service | 0% | 606 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 30 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 58 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 12 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 68 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCLAPP, STEPHEN (PRESIDENT/CEO)